New York, March 31, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Insulin Pen Needles Industry" - https://www.reportlinker.com/p06044681/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.
Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.
Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.
Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.
Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Insulin Pen Needles Market to Reach $3.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Insulin Pen Needles estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at aCAGR of 6.7% over the period 2020-2027. Standard Insulin Pen Needles, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Safety-Engineered Insulin Pen Needles segment is readjusted to a revised 7.5% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $579.7 Million, While China is Forecast to Grow at 10.2% CAGR
- The Insulin Pen Needles market in the U.S. is estimated at US$579.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$732.4 Million by the year 2027 trailing a CAGR of 10.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

- Select Competitors (Total 43 Featured) -

Becton, Dickinson & Company
Htl-Strefa S.A.
MedExel Co., Ltd.
Novo Nordisk, Inc.
Owen Mumford Ltd.
Vogt Medical Vertrieb GmbH

Read the full report: https://www.reportlinker.com/p06044681/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Insulin Pen
Needles by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Insulin Pen Needles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Insulin Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Standard Insulin
Pen Needles by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Standard Insulin Pen Needles
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Standard Insulin Pen
Needles by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 7: World Current & Future Analysis for Safety-Engineered
Insulin Pen Needles by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Safety-Engineered Insulin
Pen Needles by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Safety-Engineered
Insulin Pen Needles by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Type I Diabetes
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Type I Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Type I Diabetes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Type II Diabetes
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Type II Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Type II Diabetes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 16: USA Current & Future Analysis for Insulin Pen Needles
by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 17: USA Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 18: USA 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 19: USA Current & Future Analysis for Insulin Pen Needles
by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 20: USA Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: USA 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

CANADA
Table 22: Canada Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 23: Canada Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 24: Canada 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 25: Canada Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 26: Canada Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: Canada 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

JAPAN
Table 28: Japan Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 29: Japan Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 30: Japan 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 31: Japan Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: Japan Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 33: Japan 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

CHINA
Table 34: China Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: China Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 36: China 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 37: China Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: China Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: China 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

EUROPE
Table 40: Europe Current & Future Analysis for Insulin Pen
Needles by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 41: Europe Historic Review for Insulin Pen Needles by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Europe 15-Year Perspective for Insulin Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 43: Europe Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Europe Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 45: Europe 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 46: Europe Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Europe 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

FRANCE
Table 49: France Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: France Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 51: France 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 52: France Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 53: France Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 54: France 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

GERMANY
Table 55: Germany Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: Germany Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 57: Germany 15-Year Perspective for Insulin Pen Needles
by Product Type - Percentage Breakdown of Value Sales for
Standard Insulin Pen Needles and Safety-Engineered Insulin Pen
Needles for the Years 2012, 2020 & 2027

Table 58: Germany Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Germany Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 60: Germany 15-Year Perspective for Insulin Pen Needles
by Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

ITALY
Table 61: Italy Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: Italy Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 63: Italy 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 64: Italy Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: Italy Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: Italy 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 67: UK Current & Future Analysis for Insulin Pen Needles
by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: UK Historic Review for Insulin Pen Needles by Product
Type - Standard Insulin Pen Needles and Safety-Engineered
Insulin Pen Needles Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: UK 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 70: UK Current & Future Analysis for Insulin Pen Needles
by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: UK Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 72: UK 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

SPAIN
Table 73: Spain Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Spain Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 75: Spain 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 76: Spain Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Spain Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: Spain 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

RUSSIA
Table 79: Russia Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: Russia Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 81: Russia 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 82: Russia Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: Russia Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 84: Russia 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 85: Rest of Europe Current & Future Analysis for Insulin
Pen Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 86: Rest of Europe Historic Review for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 87: Rest of Europe 15-Year Perspective for Insulin Pen
Needles by Product Type - Percentage Breakdown of Value Sales
for Standard Insulin Pen Needles and Safety-Engineered Insulin
Pen Needles for the Years 2012, 2020 & 2027

Table 88: Rest of Europe Current & Future Analysis for Insulin
Pen Needles by Application - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 89: Rest of Europe Historic Review for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 90: Rest of Europe 15-Year Perspective for Insulin Pen
Needles by Application - Percentage Breakdown of Value Sales
for Type I Diabetes and Type II Diabetes for the Years 2012,
2020 & 2027

ASIA-PACIFIC
Table 91: Asia-Pacific Current & Future Analysis for Insulin
Pen Needles by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 92: Asia-Pacific Historic Review for Insulin Pen Needles
by Geographic Region - Australia, India, South Korea and Rest
of Asia-Pacific Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Asia-Pacific 15-Year Perspective for Insulin Pen
Needles by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 94: Asia-Pacific Current & Future Analysis for Insulin
Pen Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 95: Asia-Pacific Historic Review for Insulin Pen Needles
by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 96: Asia-Pacific 15-Year Perspective for Insulin Pen
Needles by Product Type - Percentage Breakdown of Value Sales
for Standard Insulin Pen Needles and Safety-Engineered Insulin
Pen Needles for the Years 2012, 2020 & 2027

Table 97: Asia-Pacific Current & Future Analysis for Insulin
Pen Needles by Application - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 98: Asia-Pacific Historic Review for Insulin Pen Needles
by Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 99: Asia-Pacific 15-Year Perspective for Insulin Pen
Needles by Application - Percentage Breakdown of Value Sales
for Type I Diabetes and Type II Diabetes for the Years 2012,
2020 & 2027

AUSTRALIA
Table 100: Australia Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: Australia Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 102: Australia 15-Year Perspective for Insulin Pen
Needles by Product Type - Percentage Breakdown of Value Sales
for Standard Insulin Pen Needles and Safety-Engineered Insulin
Pen Needles for the Years 2012, 2020 & 2027

Table 103: Australia Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: Australia Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Australia 15-Year Perspective for Insulin Pen
Needles by Application - Percentage Breakdown of Value Sales
for Type I Diabetes and Type II Diabetes for the Years 2012,
2020 & 2027

INDIA
Table 106: India Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 107: India Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 108: India 15-Year Perspective for Insulin Pen Needles by
Product Type - Percentage Breakdown of Value Sales for Standard
Insulin Pen Needles and Safety-Engineered Insulin Pen Needles
for the Years 2012, 2020 & 2027

Table 109: India Current & Future Analysis for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 110: India Historic Review for Insulin Pen Needles by
Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 111: India 15-Year Perspective for Insulin Pen Needles by
Application - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 112: South Korea Current & Future Analysis for Insulin
Pen Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 113: South Korea Historic Review for Insulin Pen Needles
by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 114: South Korea 15-Year Perspective for Insulin Pen
Needles by Product Type - Percentage Breakdown of Value Sales
for Standard Insulin Pen Needles and Safety-Engineered Insulin
Pen Needles for the Years 2012, 2020 & 2027

Table 115: South Korea Current & Future Analysis for Insulin
Pen Needles by Application - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 116: South Korea Historic Review for Insulin Pen Needles
by Application - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 117: South Korea 15-Year Perspective for Insulin Pen
Needles by Application - Percentage Breakdown of Value Sales
for Type I Diabetes and Type II Diabetes for the Years 2012,
2020 & 2027

REST OF ASIA-PACIFIC
Table 118: Rest of Asia-Pacific Current & Future Analysis for
Insulin Pen Needles by Product Type - Standard Insulin Pen
Needles and Safety-Engineered Insulin Pen Needles - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 119: Rest of Asia-Pacific Historic Review for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 120: Rest of Asia-Pacific 15-Year Perspective for Insulin
Pen Needles by Product Type - Percentage Breakdown of Value
Sales for Standard Insulin Pen Needles and Safety-Engineered
Insulin Pen Needles for the Years 2012, 2020 & 2027

Table 121: Rest of Asia-Pacific Current & Future Analysis for
Insulin Pen Needles by Application - Type I Diabetes and Type
II Diabetes - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 122: Rest of Asia-Pacific Historic Review for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 123: Rest of Asia-Pacific 15-Year Perspective for Insulin
Pen Needles by Application - Percentage Breakdown of Value
Sales for Type I Diabetes and Type II Diabetes for the Years
2012, 2020 & 2027

LATIN AMERICA
Table 124: Latin America Current & Future Analysis for Insulin
Pen Needles by Geographic Region - Argentina, Brazil, Mexico
and Rest of Latin America Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 125: Latin America Historic Review for Insulin Pen
Needles by Geographic Region - Argentina, Brazil, Mexico and
Rest of Latin America Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 126: Latin America 15-Year Perspective for Insulin Pen
Needles by Geographic Region - Percentage Breakdown of Value
Sales for Argentina, Brazil, Mexico and Rest of Latin America
Markets for Years 2012, 2020 & 2027

Table 127: Latin America Current & Future Analysis for Insulin
Pen Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 128: Latin America Historic Review for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 129: Latin America 15-Year Perspective for Insulin Pen
Needles by Product Type - Percentage Breakdown of Value Sales
for Standard Insulin Pen Needles and Safety-Engineered Insulin
Pen Needles for the Years 2012, 2020 & 2027

Table 130: Latin America Current & Future Analysis for Insulin
Pen Needles by Application - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 131: Latin America Historic Review for Insulin Pen
Needles by Application - Type I Diabetes and Type II Diabetes
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 132: Latin America 15-Year Perspective for Insulin Pen
Needles by Application - Percentage Breakdown of Value Sales
for Type I Diabetes and Type II Diabetes for the Years 2012,
2020 & 2027

ARGENTINA
Table 133: Argentina Current & Future Analysis for Insulin Pen
Needles by Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 134: Argentina Historic Review for Insulin Pen Needles by
Product Type - Standard Insulin Pen Needles and
Safety-Engineered Insulin Pen Needles Markets - Independent

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06044681/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Insulin Pen Needles Market to Reach $3.4 Billion by 2027

Contact